vs
Side-by-side financial comparison of Organon & Co. (OGN) and RXO, Inc. (RXO). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.5B, roughly 1.0× RXO, Inc.). RXO, Inc. runs the higher net margin — -3.1% vs -13.6%, a 10.5% gap on every dollar of revenue. On growth, Organon & Co. posted the faster year-over-year revenue change (-5.3% vs -11.9%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $-9.0M). Over the past eight quarters, RXO, Inc.'s revenue compounded faster (26.8% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
RXO, Inc. is a leading transportation and logistics solutions provider headquartered in the United States. Its core service portfolio includes freight brokerage, last-mile delivery for heavy and bulky goods, managed transportation services, and end-to-end supply chain optimization support, primarily catering to clients across the North American manufacturing, retail, and e-commerce segments.
OGN vs RXO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.5B |
| Net Profit | $-205.0M | $-46.0M |
| Gross Margin | 49.2% | — |
| Operating Margin | -9.8% | -2.9% |
| Net Margin | -13.6% | -3.1% |
| Revenue YoY | -5.3% | -11.9% |
| Net Profit YoY | -288.1% | -84.0% |
| EPS (diluted) | $-0.78 | $-0.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.6B | $1.4B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.6B | $1.0B | ||
| Q2 24 | $1.6B | $930.0M | ||
| Q1 24 | $1.6B | $913.0M |
| Q4 25 | $-205.0M | $-46.0M | ||
| Q3 25 | $160.0M | $-14.0M | ||
| Q2 25 | $145.0M | $-9.0M | ||
| Q1 25 | $87.0M | $-31.0M | ||
| Q4 24 | $109.0M | $-25.0M | ||
| Q3 24 | $359.0M | $-243.0M | ||
| Q2 24 | $195.0M | $-7.0M | ||
| Q1 24 | $201.0M | $-15.0M |
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | — | ||
| Q1 24 | 59.0% | — |
| Q4 25 | -9.8% | -2.9% | ||
| Q3 25 | 15.2% | -0.5% | ||
| Q2 25 | 14.4% | — | ||
| Q1 25 | 6.7% | -2.1% | ||
| Q4 24 | 8.1% | -1.4% | ||
| Q3 24 | 13.1% | -1.9% | ||
| Q2 24 | 14.6% | — | ||
| Q1 24 | 14.5% | -1.3% |
| Q4 25 | -13.6% | -3.1% | ||
| Q3 25 | 10.0% | -1.0% | ||
| Q2 25 | 9.1% | -0.6% | ||
| Q1 25 | 5.8% | -2.2% | ||
| Q4 24 | 6.8% | -1.5% | ||
| Q3 24 | 22.7% | -23.4% | ||
| Q2 24 | 12.1% | -0.8% | ||
| Q1 24 | 12.4% | -1.6% |
| Q4 25 | $-0.78 | $-0.28 | ||
| Q3 25 | $0.61 | $-0.08 | ||
| Q2 25 | $0.56 | $-0.05 | ||
| Q1 25 | $0.33 | $-0.18 | ||
| Q4 24 | $0.42 | $-0.17 | ||
| Q3 24 | $1.38 | $-1.81 | ||
| Q2 24 | $0.75 | $-0.06 | ||
| Q1 24 | $0.78 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $17.0M |
| Total DebtLower is stronger | $8.6B | $387.0M |
| Stockholders' EquityBook value | $752.0M | $1.5B |
| Total Assets | $12.9B | $3.3B |
| Debt / EquityLower = less leverage | 11.49× | 0.25× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $17.0M | ||
| Q3 25 | $672.0M | $25.0M | ||
| Q2 25 | $599.0M | $18.0M | ||
| Q1 25 | $547.0M | $16.0M | ||
| Q4 24 | $675.0M | $35.0M | ||
| Q3 24 | $763.0M | $55.0M | ||
| Q2 24 | $704.0M | $7.0M | ||
| Q1 24 | $575.0M | $7.0M |
| Q4 25 | $8.6B | $387.0M | ||
| Q3 25 | $8.8B | $387.0M | ||
| Q2 25 | $8.9B | $387.0M | ||
| Q1 25 | $9.0B | $387.0M | ||
| Q4 24 | $8.9B | $351.0M | ||
| Q3 24 | $8.7B | $352.0M | ||
| Q2 24 | $8.7B | $370.0M | ||
| Q1 24 | $8.7B | $351.0M |
| Q4 25 | $752.0M | $1.5B | ||
| Q3 25 | $906.0M | $1.6B | ||
| Q2 25 | $733.0M | $1.6B | ||
| Q1 25 | $542.0M | $1.6B | ||
| Q4 24 | $472.0M | $1.6B | ||
| Q3 24 | $493.0M | $1.7B | ||
| Q2 24 | $144.0M | $579.0M | ||
| Q1 24 | $48.0M | $582.0M |
| Q4 25 | $12.9B | $3.3B | ||
| Q3 25 | $13.6B | $3.2B | ||
| Q2 25 | $13.5B | $3.2B | ||
| Q1 25 | $13.2B | $3.3B | ||
| Q4 24 | $13.1B | $3.4B | ||
| Q3 24 | $12.8B | $3.4B | ||
| Q2 24 | $12.2B | $1.8B | ||
| Q1 24 | $11.9B | $1.8B |
| Q4 25 | 11.49× | 0.25× | ||
| Q3 25 | 9.74× | 0.24× | ||
| Q2 25 | 12.14× | 0.24× | ||
| Q1 25 | 16.52× | 0.24× | ||
| Q4 24 | 18.81× | 0.22× | ||
| Q3 24 | 17.75× | 0.21× | ||
| Q2 24 | 60.11× | 0.64× | ||
| Q1 24 | 181.54× | 0.60× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $7.0M |
| Free Cash FlowOCF − Capex | $96.0M | $-9.0M |
| FCF MarginFCF / Revenue | 6.4% | -0.6% |
| Capex IntensityCapex / Revenue | 3.0% | 1.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | $-8.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $7.0M | ||
| Q3 25 | $264.0M | $23.0M | ||
| Q2 25 | $220.0M | $23.0M | ||
| Q1 25 | $75.0M | $-2.0M | ||
| Q4 24 | $390.0M | $-7.0M | ||
| Q3 24 | $141.0M | $-7.0M | ||
| Q2 24 | $332.0M | $-5.0M | ||
| Q1 24 | $76.0M | $7.0M |
| Q4 25 | $96.0M | $-9.0M | ||
| Q3 25 | $218.0M | $9.0M | ||
| Q2 25 | $181.0M | $9.0M | ||
| Q1 25 | $43.0M | $-17.0M | ||
| Q4 24 | $335.0M | $-19.0M | ||
| Q3 24 | $99.0M | $-18.0M | ||
| Q2 24 | $300.0M | $-16.0M | ||
| Q1 24 | $30.0M | $-4.0M |
| Q4 25 | 6.4% | -0.6% | ||
| Q3 25 | 13.6% | 0.6% | ||
| Q2 25 | 11.4% | 0.6% | ||
| Q1 25 | 2.8% | -1.2% | ||
| Q4 24 | 21.0% | -1.1% | ||
| Q3 24 | 6.3% | -1.7% | ||
| Q2 24 | 18.7% | -1.7% | ||
| Q1 24 | 1.8% | -0.4% |
| Q4 25 | 3.0% | 1.1% | ||
| Q3 25 | 2.9% | 1.0% | ||
| Q2 25 | 2.4% | 1.0% | ||
| Q1 25 | 2.1% | 1.0% | ||
| Q4 24 | 3.5% | 0.7% | ||
| Q3 24 | 2.7% | 1.1% | ||
| Q2 24 | 2.0% | 1.2% | ||
| Q1 24 | 2.8% | 1.2% |
| Q4 25 | — | — | ||
| Q3 25 | 1.65× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 1.70× | — | ||
| Q1 24 | 0.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
RXO
| Retail Sector | $546.0M | 37% |
| Last Mile | $298.0M | 20% |
| Food And Beverage Sector | $225.0M | 15% |
| Other Sector | $185.0M | 13% |
| Managed Transportation | $133.0M | 9% |
| Automotive Sector | $93.0M | 6% |
